ORLANDO, Fla. — (BUSINESS WIRE) — July 17, 2014 — Mazor Robotics, Ltd. (TASE: MZOR; NASDAQ GM: MZOR), a developer of innovative guidance systems and complementary products, announced results of data being presented July 16-19 at the 21st International Meeting on Advanced Spine Techniques (IMAST) meeting in Valencia, Spain.
An e-poster entitled, Retrospective, Five-Center Analysis of 3,270 Pedicle Screws Placed with Robotic Guidance in Adolescent Idiopathic Scoliosis (AIS), reports that 223 patients with AIS in five centers, had a total of 3,270 pedicle screws placed using the Renaissance system with over 99 percent accuracy.
A podium presentation, entitled, Retrospective Analysis of Feasibility and Performance of Robotic Guidance for Placement of Pedicle Screws in 223 Adolescents with Idiopathic Scoliosis (AIS), highlights that 3,270 screws were placed with the Renaissance system while fluoroscopy use was limited to 1.58 seconds per screw.
“Anatomic constraints in AIS frequently confound placement of pedicle screws, especially when instrumenting the most deformed regions of a curved spine,” said Dr. Dennis P. Devito of Children’s Healthcare of Atlanta, one of the lead investigators of the study. “The accuracy of screw placement and reduced exposure to radiation per case results in safer operations for both the patient and surgical staff.”
Other researchers involved in the study included:
Dr. Isador Lieberman, Texas Back Institute, Plano, TX
Dr. Samuel Bederman, UC Irvine Medical Center, Irvine, CA
Dr. Raymond Woo, Florida Hospital for Children, Orlando, FL
Dr. Sajan Hegde, Apollo Hospitals Chennai, Chennai, India
About The Renaissance System
Mazor Robotics Renaissance system is the only mechanical guidance system cleared by the US Food and Drug Administration for use in both spine and brain surgery.
To date, thousands of spine procedures have been performed with the Renaissance system, ranging from minimally-invasive one-level fusions to complex deformity reconstructions.
About Mazor
Mazor Robotics is dedicated to the development and marketing of innovative surgical guidance systems and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance®, is a state-of-the-art surgical guidance system that enables surgeons to conduct spine and brain procedures in an accurate and secure manner. Mazor Robotics systems have been successfully used in the placement of over 45,000 implants worldwide. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology. For more information, the content of which is not part of this press release, please visit www.mazorrobotics.com.
Contact:
U.S. Contacts: EVC Group
Investors:
Michael Polyviou,
212-850-6020
Email Contact
Robert
Jones, 646-201-5447
Email Contact
or
Media:
Dave
Schemelia, 646-201-5431
Email Contact
